AlphaYouADPT: RUBINSTEIN JULIE discloses securities transactions
By AlphaYouPublished Form 4
RUBINSTEIN JULIE
Reporting filer
RUBINSTEIN JULIE reported Exercise or conversion in Adaptive Biotechnologies Corp: 11881 units of Common Stock, dated 2026-10-01. The full Form 4 contains 11 transaction entries.
- Disclosed
- Oct 6, 2026
Reported details
11 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | RUBINSTEIN JULIE | 2026-10-01 | M | Exercise or conversion | 11881 | 12.14 | 389,683 | 5 days | Filed terms
|
| Common Stock | RUBINSTEIN JULIE | 2026-10-01 | S | Sale | 6081 | 27.57 | 383,602 | 5 days | Filed terms
|
| Common Stock | RUBINSTEIN JULIE | 2026-10-01 | S | Sale | 5800 | 28.56 | 377,802 | 5 days | Filed terms
|
| Common Stock | RUBINSTEIN JULIE | 2026-10-02 | M | Exercise or conversion | 11881 | 12.14 | 389,683 | 4 days | Filed terms
|
| Common Stock | RUBINSTEIN JULIE | 2026-10-02 | S | Sale | 11881 | 28.13 | 377,802 | 4 days | Filed terms
|
| Common Stock | RUBINSTEIN JULIE | 2026-10-05 | M | Exercise or conversion | 11881 | 12.14 | 389,683 | 1 day | Filed terms
|
| Common Stock | RUBINSTEIN JULIE | 2026-10-05 | S | Sale | 6699 | 28.82 | 382,984 | 1 day | Filed terms
|
| Common Stock | RUBINSTEIN JULIE | 2026-10-05 | S | Sale | 5182 | 29.67 | 377,802 | 1 day | Filed terms
|
| Stock Option (right to buy) (derivative) | RUBINSTEIN JULIE | 2026-10-01 | M | Exercise or conversion | 11881 | 0 | 367,896 | 5 days | Filed terms
|
| Stock Option (right to buy) (derivative) | RUBINSTEIN JULIE | 2026-10-02 | M | Exercise or conversion | 11881 | 0 | 356,015 | 4 days | Filed terms
|
| Stock Option (right to buy) (derivative) | RUBINSTEIN JULIE | 2026-10-05 | M | Exercise or conversion | 11881 | 0 | 344,134 | 1 day | Filed terms
|
Common Stock
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-01
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 11881
- Price
- 12.14
- Following holdings
- 389,683
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 11881
- transaction Price Per Share: 12.14
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 389683
- direct Or Indirect Ownership: D
Common Stock
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-01
- Code
- S
- Action
- Sale
- Quantity
- 6081
- Price
- 27.57
- Following holdings
- 383,602
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 6081
- transaction Price Per Share: 27.57
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 383602
- direct Or Indirect Ownership: D
Common Stock
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-01
- Code
- S
- Action
- Sale
- Quantity
- 5800
- Price
- 28.56
- Following holdings
- 377,802
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 5800
- transaction Price Per Share: 28.56
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 377802
- direct Or Indirect Ownership: D
Common Stock
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-02
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 11881
- Price
- 12.14
- Following holdings
- 389,683
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 11881
- transaction Price Per Share: 12.14
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 389683
- direct Or Indirect Ownership: D
Common Stock
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 11881
- Price
- 28.13
- Following holdings
- 377,802
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 11881
- transaction Price Per Share: 28.13
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 377802
- direct Or Indirect Ownership: D
Common Stock
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-05
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 11881
- Price
- 12.14
- Following holdings
- 389,683
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-05
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 11881
- transaction Price Per Share: 12.14
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 389683
- direct Or Indirect Ownership: D
Common Stock
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-05
- Code
- S
- Action
- Sale
- Quantity
- 6699
- Price
- 28.82
- Following holdings
- 382,984
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-05
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 6699
- transaction Price Per Share: 28.82
- id: F5
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 382984
- direct Or Indirect Ownership: D
Common Stock
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-05
- Code
- S
- Action
- Sale
- Quantity
- 5182
- Price
- 29.67
- Following holdings
- 377,802
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-05
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 5182
- transaction Price Per Share: 29.67
- id: F6
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 377802
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-01
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 11881
- Price
- 0
- Following holdings
- 367,896
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 12.14
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 11881
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F7
- expiration Date: 2032-03-04
- underlying Security Title: Common Stock
- underlying Security Shares: 11881
- shares Owned Following Transaction: 367896
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-02
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 11881
- Price
- 0
- Following holdings
- 356,015
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 12.14
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 11881
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F7
- expiration Date: 2032-03-04
- underlying Security Title: Common Stock
- underlying Security Shares: 11881
- shares Owned Following Transaction: 356015
- direct Or Indirect Ownership: D
Stock Option (right to buy) (derivative)
- Owner
- RUBINSTEIN JULIE
- Date
- 2026-10-05
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 11881
- Price
- 0
- Following holdings
- 344,134
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 12.14
- transaction Date: 2026-10-05
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 11881
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F7
- expiration Date: 2032-03-04
- underlying Security Title: Common Stock
- underlying Security Shares: 11881
- shares Owned Following Transaction: 344134
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- RUBINSTEIN JULIE: President and COO.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.
- F2: The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $28.11, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- F3: The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.22 to $28.83, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- F4: The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.62 to $28.37, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- F5: The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.30 to $29.29, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- F6: The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.32 to $29.82, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- F7: The option is fully vested and exercisable.
Original sources
Prepared automatically from public filing data. Report a correction.